9 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and InfantsBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisNot yet recruitingPhase 1 / Phase 22026-06-24NCT07666750
Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisActive, not recruitingPhase 32026-04-01NCT06838195
The Impact of Shigellosis and Recommended Treatment in ChildrenBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, bacterial infectious disease, diarrheal disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisRecruitingPhase 22026-03-30NCT07433426
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young AdultsBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, bacterial infectious disease, diarrheal disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisRecruitingPhase 12025-11-19NCT07205926
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years OldBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisRecruitingPhase 22025-07-08NCT07049159
Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of ShigellosisBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisActive, not recruitingPhase 1 / Phase 22025-06-15NCT05182749
Shigella Sonnei 53G Human Infection Study in Kenyan AdultsBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisRecruitingPhase 12025-03-13NCT05959616
Enterics for Global Health (EFGH)Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, bacterial infectious disease, diarrheal disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisActive, not recruitingNot stated2025-01-14NCT06047821
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and ZambiaBacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, bacterial infectious disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosisRecruitingPhase 12024-11-07NCT05961059